Total Funding
25
62
Total FundingPost-IPO Debt raised
Growth Score
-4 pts
Heat Score
1 pts
Company Performance Metrics
Score
Trend
AI Content may contain mistakes and is not legal, financial or investment advice.Learn more.
Growth Score - The measure of growth based on company activity, operational metrics, and investments
Growth Trend - The change in the growth score over the given time period
Heat Score - The measure of the market interest, media activity, and Crunchbase profile activity
Heat Trend - The change in the heat score over the given time period
See more interactive data and historical milestones on desktop for the best experience
97084
SurModics provides a surface modification and in vitro diagnostic technologies to the healthcare industry.
- Pearse O'Donohue: VP of Operations
Arthur J. Tipton: Senior Vice President and General Manager
About the Company
SurModics provides surface modification and in vitro diagnostic technologies to the healthcare industry. It also develops and commercializes highly differentiated vascular intervention medical devices designed to address unmet clinical needs and engineered to the most demanding requirements. This key growth strategy leverages the combination of the
company’s expertise in proprietary surface modification and drug-delivery coating technologies, along with its device design, development, and manufacturing capabilities.
